NEOGEN CORP
Financial highlights
| Metric | FY 05/31/25 | FY 05/31/24 | FY 05/31/23 | FY 05/31/22 | FY 05/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $894.7M | $924.2M | $822.4M | $527.2M | $468.5M |
| Cost of revenue | $473.3M | $460.3M | $416.5M | $284.1M | $253.4M |
| Gross profit | $421.4M | $463.9M | $406.0M | $243.0M | $215.1M |
| Research and development | $21.1M | $22.5M | $26.0M | $17.0M | $16.2M |
| Operating expenses | $1.5B | $405.2M | $368.4M | $184.4M | $140.9M |
| Operating income | -$1.1B | $58.7M | $37.5M | $58.6M | $74.2M |
| Interest expense | $38.1M | $42.2M | $27.3M | — | — |
| Pretax income | -$1.1B | -$14.3M | -$22.0M | $60.2M | $75.3M |
| Income tax expense | -$41.1M | -$4.9M | $828,000 | $11.9M | $14.4M |
| Net income | -$1.1B | -$9.4M | -$22.9M | $48.3M | $60.9M |
| Balance Sheet | |||||
| Cash and equivalents | $129.0M | $170.6M | $163.2M | $44.5M | $75.6M |
| Current assets | $576.9M | $589.2M | $585.9M | $626.8M | $591.5M |
| Total assets | $3.4B | $4.5B | $4.6B | $992.9M | $920.2M |
| Current liabilities | $174.0M | $154.3M | $145.5M | $77.8M | $53.6M |
| Total liabilities | $1.4B | $1.4B | $1.4B | $105.6M | $79.8M |
| Total debt | $902.4M | $902.4M | $900.0M | — | — |
| Stockholders' equity | $2.1B | $3.1B | $3.1B | $887.4M | $840.4M |
| Cash Flow Statement | |||||
| Cash from operations | $58.2M | $35.3M | $41.0M | $68.0M | $81.1M |
| Depreciation and amortization | $119.5M | $116.7M | $88.4M | $23.7M | $21.0M |
| Stock-based compensation | $17.3M | $13.8M | $10.2M | $7.2M | $6.4M |
| Capital expenditure | $104.6M | $111.4M | $65.8M | $24.4M | $26.7M |
| Free cash flow | -$46.4M | -$76.2M | -$24.7M | $43.6M | $54.4M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 217.7M · Free float 99.4%
Annual filing data through FY ended May 31, 2025; float as of July 8, 2026.